{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:51:06Z","timestamp":1790661066481,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"Abstract<\/jats:title>\n Introduction<\/jats:title>\n There are currently limited data regarding the clinical and economic significance of skin and soft tissue infections (SSTI) and bone and joint infections in Australian people who inject drugs (PWID).<\/jats:p>\n <\/jats:sec>\n Methods<\/jats:title>\n Retrospective cohort study in adult PWID admitted to Monash Health, a large heath care network with six hospitals in Victoria, Australia. Inpatients were identified using administrative datasets and International Classification of Disease (ICD-10) coding for specific infection-related conditions. Cost analysis was based on mean ward, intensive care and hospital-in-the-home (HITH) lengths of stay. Spinal infections and endocarditis were excluded as part of previous studies.<\/jats:p>\n <\/jats:sec>\n Results<\/jats:title>\n A total of 185 PWID (61 female, 124 male, median age 37) meeting the study criteria were admitted to Monash Health between January 2010 and January 2021. Admitting diagnoses included 78 skin abscesses, 80 cellulitis, 17 septic arthritis, 4 osteomyelitis, 3 thrombophlebitis and 1 each of necrotising fasciitis, vasculitis and myositis. Pain (87.5%) and swelling (75.1%) were the most common presenting complaints. Opioids (67.4%) and methamphetamine (37.5%) were the most common primary drugs injected. Almost half (46.5%) of patients had concurrent active hepatitis C (HCV) infection on admission. Hepatitis B (HBV) and Human Immunodeficiency Virus (HIV) were uncommon. The most significant causative organism was methicillin-susceptible Staphylococcus aureus<\/jats:italic> (24.9%). In 40.0% (74\/185) no organism was identified. Patients required a median acute hospital stay of 5 days (2\u201351 days). There were 15 patients admitted to the intensive care unit (ICU) with median duration 2 days. PICC line insertion for antibiotics was required in 16.8% of patients, while 51.4% required surgical intervention. Median duration of both oral and IV antibiotic therapy was 11 days. Almost half (48.6%) of patients were enrolled in an opioid maintenance program on discharge. Average estimated expenditure was AUD $16, 528 per admission.<\/jats:p>\n <\/jats:sec>\n Conclusion<\/jats:title>\n Skin and soft tissue and joint infections are a major cause of morbidity for PWID. Admission to hospital provides opportunistic involvement of addiction specialty services.<\/jats:p>\n <\/jats:sec>","DOI":"10.1186\/s12879-024-09143-0","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T07:02:34Z","timestamp":1709794954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs"],"prefix":"10.1186","volume":"24","author":[{"given":"B.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Boyagoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ananda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LO","family":"Attwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Woolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"issue":"1","key":"9143_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-017-4785-7","volume":"17","author":"S Larney","year":"2017","unstructured":"Larney S, Hickman M, Guy R, Grebely J, Dore GJ, Gray RT, et al. Estimating the number of people who inject drugs in Australia. BMC Public Health. 2017;17(1):1\u20137.","journal-title":"BMC Public Health"},{"key":"9143_CR2","unstructured":"Sutherland RU, King J, Jones C, Karlsson F, Gibbs A, Price D, Raimondo O, Dietze B, Lenton P, Salom S, Daly C, Thomas C, Juckel N, Agramunt J, Wilson S, Que Noy Y, Wilson W, Degenhardt J, Farrel L, Peacock M. A. Australian drug Trends 2022: key findings from the national illicit drug reporting system (IDRS) interviews. Australian Institute of Health and Welfare; 2022."},{"issue":"8","key":"9143_CR3","doi-asserted-by":"publisher","first-page":"e014854","DOI":"10.1136\/bmjopen-2016-014854","volume":"7","author":"D Nambiar","year":"2017","unstructured":"Nambiar D, Stoov\u00e9 M, Hickman M, Dietze P. A prospective cohort study of hospital separations among people who inject drugs in Australia: 2008\u20132013. BMJ open. 2017;7(8):e014854.","journal-title":"BMJ open"},{"issue":"1","key":"9143_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.idc.2020.10.006","volume":"35","author":"H Chambers","year":"2021","unstructured":"Chambers H. Skin and Soft Tissue Infections in persons who inject drugs. Infect Dis Clin N Am. 2021;35(1):169\u201381.","journal-title":"Infect Dis Clin N Am"},{"issue":"3","key":"9143_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s10900-017-0458-9","volume":"43","author":"MG Collier","year":"2018","unstructured":"Collier MG, Doshani M, Asher A. Using Population based Hospitalization Data to Monitor increases in conditions causing morbidity among persons who inject drugs. J Community Health. 2018;43(3):598\u2013603.","journal-title":"J Community Health"},{"issue":"1","key":"9143_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00447-3","volume":"17","author":"A Baltes","year":"2020","unstructured":"Baltes A, Akhtar W, Birstler J, Olson-Streed H, Eagen K, Seal D, et al. Predictors of skin and soft tissue infections among sample of rural residents who inject drugs. Harm Reduct J. 2020;17(1):1\u201310.","journal-title":"Harm Reduct J"},{"key":"9143_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.drugalcdep.2017.01.020","volume":"174","author":"K Dunleavy","year":"2017","unstructured":"Dunleavy K, Munro A, Roy K, Hutchinson S, Palmateer N, Knox T, et al. Association between harm reduction intervention uptake and skin and soft tissue infections among people who inject drugs. Drug Alcohol Depend. 2017;174:91\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"9143_CR8","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/cid\/ciy924","volume":"68","author":"LR Marks","year":"2019","unstructured":"Marks LR, Munigala S, Warren DK, Liang SY, Schwarz ES, Durkin MJ. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis. 2019;68(11):1935\u20137.","journal-title":"Clin Infect Dis"},{"key":"9143_CR9","doi-asserted-by":"crossref","unstructured":"Ananda RA, Attwood LO, Lancaster R, Jacka D, Jhoomun T, Danks A et al. The clinical and financial burden of spinal infections in people who inject drugs. Intern Med J. 2021.","DOI":"10.1111\/imj.15397"},{"issue":"10","key":"9143_CR10","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/imj.14717","volume":"50","author":"ZM Low","year":"2020","unstructured":"Low ZM, Krishnaswamy S, Woolley IJ, Stuart RL, Boers A, Barton TL, et al. Burden of infective endocarditis in an Australian cohort of people who inject drugs. Intern Med J. 2020;50(10):1240\u20136.","journal-title":"Intern Med J"},{"issue":"2","key":"9143_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"9143_CR12","volume-title":"R: a languange and environment for statistical computing","author":"R Development Core Team","year":"2021","unstructured":"R Development Core Team. R: a languange and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021."},{"issue":"6","key":"9143_CR13","doi-asserted-by":"publisher","first-page":"924","DOI":"10.15288\/jsad.2008.69.924","volume":"69","author":"IA Binswanger","year":"2008","unstructured":"Binswanger IA, Takahashi TA, Bradley K, Dellit TH, Benton KL, Merrill JO. Drug users seeking emergency care for soft tissue infection at high risk for subsequent hospitalization and death. J Stud Alcohol Drug. 2008;69(6):924\u201332.","journal-title":"J Stud Alcohol Drug"},{"issue":"9","key":"9143_CR14","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMcp031807","volume":"350","author":"MN Swartz","year":"2004","unstructured":"Swartz MN, Cellulitis. N Engl J Med. 2004;350(9):904\u201312.","journal-title":"N Engl J Med"},{"issue":"Supplement2","key":"9143_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/clinids\/20.Supplement_2.S279","volume":"20","author":"PH Summanen","year":"1995","unstructured":"Summanen PH, Talan DA, Strong C, McTeague M, Bennion R, Thompson JE Jr., et al. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of Intravenous Drug Use. Clin Infect Dis. 1995;20(Supplement2):279\u2013S82.","journal-title":"Clin Infect Dis"},{"key":"9143_CR16","unstructured":"AURA. 2021: Fourth Australian report on antimicrobial use and resistance in human health. Australian Commision on Safety and Quality in Health Care; 2021."},{"issue":"12","key":"9143_CR17","doi-asserted-by":"publisher","first-page":"e00925","DOI":"10.1128\/AAC.00925-21","volume":"65","author":"MC Kelly","year":"2021","unstructured":"Kelly MC, Yeager SD, Shorman MA, Wright LR, Veve MP. Incidence and predictors of Gram-negative Bacilli in hospitalized people who inject drugs with Injection Drug Use-Attributable infections. Antimicrob Agents Chemother. 2021;65(12):e00925\u201321.","journal-title":"Antimicrob Agents Chemother"},{"key":"9143_CR18","unstructured":"Cellulitis. and erysipelas [published 2021 Aug] Melbourne Therapeutic Guidelines Limited 2021 [Available from: